TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Nordic Haemostasis AB
Closing information (x1000 NOK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 1,530 | 1,845 | 1,359 |
Financial expenses | 1 | 2 | 0 |
Earnings before taxes | 24 | 745 | 63 |
EBITDA | 26 | 747 | 64 |
Total assets | 816 | 1,018 | 622 |
Current assets | 743 | 1,018 | 622 |
Current liabilities | 129 | 267 | 287 |
Equity capital | 688 | 751 | 335 |
- share capital | 47 | 49 | 52 |
Employees (average) | 2 | 2 | 2 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 84.3% | 73.8% | 53.9% |
Turnover per employee | 765 | 922 | 680 |
Profit as a percentage of turnover | 1.6% | 40.4% | 4.6% |
Return on assets (ROA) | 3.1% | 73.4% | 10.1% |
Current ratio | 576.0% | 381.3% | 216.7% |
Return on equity (ROE) | 3.5% | 99.2% | 18.8% |
Change turnover | -260 | 580 | -6 |
Change turnover % | -15% | 46% | 0% |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.